Literature DB >> 19085923

Associations of psychosocial factors with health outcomes among youth with cystic fibrosis.

Joän M Patterson1, Melanie Wall, Jerica Berge, Carlos Milla.   

Abstract

PURPOSE: The purpose of this study was to examine the relationship of strains, resources, feelings, and behaviors about treatment adherence reported by youth with cystic fibrosis (CF) with repeated clinic measures of their pulmonary function and nutritional status.
METHODS: Linear mixed models, stratified by gender, adjusting for age, were used to examine the effects of strains, resources, and adherence behaviors on repeated pulmonary function and nutritional status measures. All 10-21 years old with CF at the Minnesota Cystic Fibrosis Center were invited by mail to participate. Of these 177 youth, 51% (43 boys, 47 girls) returned surveys. Forced expiratory volume in 1 sec and predicted weight-for-height were extracted from participants' clinic records for the 18 months following receipt of the survey.
RESULTS: Females showed significantly greater variability in repeated measures of pulmonary function and nutritional status compared to males. Parent-youth strains, physical strains, activity limitations, and cough suppression had significant effects on the 18-month mean of pulmonary function measures for females, but only physical strains had a significant effect for males.
CONCLUSION: Compared to males, females experienced more strains and poorer treatment adherence, which may be factors associated with declines in pulmonary function observed among females with CF during the adolescent years. Copyright 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2009        PMID: 19085923     DOI: 10.1002/ppul.20925

Source DB:  PubMed          Journal:  Pediatr Pulmonol        ISSN: 1099-0496


  8 in total

Review 1.  Developmental and psychosocial issues in cystic fibrosis.

Authors:  Michelle M Ernst; Mark C Johnson; Lori J Stark
Journal:  Child Adolesc Psychiatr Clin N Am       Date:  2010-04

2.  Effects of gender and age at diagnosis on disease progression in long-term survivors of cystic fibrosis.

Authors:  Jerry A Nick; Cathy S Chacon; Sara J Brayshaw; Marion C Jones; Christine M Barboa; Connie G St Clair; Robert L Young; David P Nichols; Jennifer S Janssen; Gwen A Huitt; Michael D Iseman; Charles L Daley; Jennifer L Taylor-Cousar; Frank J Accurso; Milene T Saavedra; Marci K Sontag
Journal:  Am J Respir Crit Care Med       Date:  2010-05-06       Impact factor: 21.405

3.  Respiratory medication adherence in chronic lung disease of prematurity.

Authors:  J Michael Collaco; Amanda J Kole; Kristin A Riekert; Michelle N Eakin; Sande O Okelo; Sharon A McGrath-Morrow
Journal:  Pediatr Pulmonol       Date:  2011-09-08

4.  Family Functioning and Treatment Adherence in Children and Adolescents with Cystic Fibrosis.

Authors:  Robin S Everhart; Barbara H Fiese; Joshua M Smyth; Adrienne Borschuk; Ran D Anbar
Journal:  Pediatr Allergy Immunol Pulmonol       Date:  2014-06-01       Impact factor: 1.349

Review 5.  The demographics of adverse outcomes in cystic fibrosis.

Authors:  Meghan E McGarry; Wadsworth A Williams; Susanna A McColley
Journal:  Pediatr Pulmonol       Date:  2019-11

6.  Health-related quality of life of Spanish children with cystic fibrosis.

Authors:  Iris F Groeneveld; Elena S Sosa; Margarita Pérez; Carmen Fiuza-Luces; Laura Gonzalez-Saiz; Cristian Gallardo; Luis M López-Mojares; Jonatan R Ruiz; Alejandro Lucia
Journal:  Qual Life Res       Date:  2012-01-05       Impact factor: 4.147

7.  Lung function over the life course of paediatric and adult patients with cystic fibrosis from a large multi-centre registry.

Authors:  Arul Earnest; Farhad Salimi; Claire E Wainwright; Scott C Bell; Rasa Ruseckaite; Tom Ranger; Tom Kotsimbos; Susannah Ahern
Journal:  Sci Rep       Date:  2020-10-15       Impact factor: 4.379

8.  Cough suppression and HRQoL in adult people with cystic fibrosis: an unexplored correlation.

Authors:  Raphael Hirtz; Florian Stehling; Ute Niehammer; Mathis Steindor; Svenja Straßburg; Sivagurunathan Sutharsan; Christian Taube; Matthias Welsner
Journal:  Health Qual Life Outcomes       Date:  2022-10-06       Impact factor: 3.077

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.